Group One Trading LLC Takes $2.42 Million Position in SPDR S&P Biotech ETF $XBI

Group One Trading LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 24,191 shares of the exchange traded fund’s stock, valued at approximately $2,424,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Erste Asset Management GmbH purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at about $100,000. Mill Creek Capital Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $213,000. Integrated Advisors Network LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $213,000. Mesirow Financial Investment Management Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 13.8% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 5,167 shares of the exchange traded fund’s stock worth $518,000 after acquiring an additional 626 shares during the last quarter. Finally, K.J. Harrison & Partners Inc boosted its position in shares of SPDR S&P Biotech ETF by 275.9% during the 3rd quarter. K.J. Harrison & Partners Inc now owns 21,800 shares of the exchange traded fund’s stock worth $2,236,000 after purchasing an additional 16,000 shares during the period.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $124.00 on Friday. The company has a market capitalization of $8.29 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $132.09. The firm has a 50 day moving average price of $125.17 and a 200 day moving average price of $113.95.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.